Anzeige
Mehr »
Dienstag, 25.11.2025 - Börsentäglich über 12.000 News
Goldrausch 2.0: 60% Insideranteil - warum dieser Gold-Explorer als Geheimtipp gilt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EYA0 | ISIN: US86272A3059 | Ticker-Symbol: E2O
Lang & Schwarz
25.11.25 | 07:00
2,050 Euro
-100,00 % -2,050
1-Jahres-Chart
STRATA SKIN SCIENCES INC Chart 1 Jahr
5-Tage-Chart
STRATA SKIN SCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,0402,06007:00

Aktuelle News zur STRATA SKIN SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.11.STRATA Skin Sciences, Inc. - 10-Q, Quarterly Report-
14.11.Strata Skin Sciences outlines threefold market expansion opportunity as CPT code revisions approach 20272
STRATA SKIN SCIENCES Aktie jetzt für 0€ handeln
13.11.STRATA Skin Sciences GAAP EPS of -$0.36 beats by $0.17, revenue of $6.93M misses by $0.79M1
12.11.A Peek at Strata Skin Sciences' Future Earnings1
06.11.STRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion1
05.11.STRATA Skin Sciences, Inc.: STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update1
29.10.STRATA Skin Sciences Rises 25% Pre-Market - Here's Why1
16.10.Strata Skin Sciences reicht Prospektnachtrag für mögliches Aktienangebot über 11 Millionen US-Dollar ein1
14.10.STRATA Skin Sciences, Inc. - 8-K, Current Report1
14.10.STRATA Skin Sciences, Inc.: Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides121First English-language case study shows resolution of lesions with 308-nm Excimer laser in rare mycosis fungoides (MF) subtype, poikilodermatous mycosis fungiodes (pMF), underscoring the Company's...
► Artikel lesen
03.10.Strata Skin Sciences highlights excimer laser efficacy for eczema2
03.10.Strata Skin Sciences: Klinische Daten stützen Excimer-Laser-Therapie bei Ekzemen1
03.10.STRATA Skin Sciences, Inc.: Marking Eczema Awareness Month - Clinical Research Validates Strata Skin Sciences' XTRAC Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis1
30.09.STRATA Skin Sciences, Inc.: STRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC Excimer Laser Treatment Combined with a Topical Drug in Psoriasis1
23.09.Aktie von STRATA Skin Sciences schießt nach vielversprechender Vitiligo-Studie in die Höhe1
23.09.STRATA Skin Sciences stock soars after promising vitiligo study results1
22.09.STRATA Skin Sciences, Inc.: New Peer Reviewed Publication of Combination Therapy in Vitiligo with STRATA Skin Sciences' Excimer Laser and JAK Inhibitors Demonstrated Superior Safety and Unprecedented Response Rates, Providing Continued Validation ...9
04.09.STRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering2
04.09.Strata Skin Sciences reports growth from E360 consulting program1
04.09.STRATA Skin Sciences, Inc.: STRATA Skin Sciences' Elevate 360 Consulting Offering Drives Growth in Partner Clinic Operations and Fuels New Partnership Agreements1
Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1